DrugPatentWatch Database Preview
Biologic Patents Expiring in 2039
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Biologic Patents With Estimated Expirations in 2039
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | YALE UNIVERSITY (New Haven, CT) | 2039-02-26 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | XL-protein GmbH (Freising, DE) Jazz Pharmaceuticals Ireland Limited (Dublin, IE) | 2039-02-26 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | GENOSCIENCE PHARMA (Marseilles, FR) | 2039-02-26 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | ARROMAX PHARMATECH CO., LTD. (Suzhou, Jiangsu, CN) | 2039-02-26 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | New York University (New York, NY) | 2039-03-15 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | JIANGNAN UNIVERSITY (Wuxi, CN) | 2039-07-18 | RX | search | |
| Merck | ELSPAR | asparaginase | VIAL | 101063 | 001 | 1978-01-10 | Start Trial | Midwest Research Institute (Kansas City, MO) | 2039-03-29 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
